PILOT STUDY FOR HPB-84 SHOWS POSITIVE RESULTS

Patients participating in a 12-week pilot study for the Type II diabetes supplement HPB-84 successfully reduced blood glucose levels as well as their dependence on oral medication, reported HEE Corporation, the manufacturer of HPB-84.

The pilot study, which involved 10 test subjects, was conducted to evaluate the efficacy of HPB-84, the breakthrough nutraceutical that safely and effectively addresses the three major issues of Type II diabetes by reducing blood sugar levels and insulin resistance while promoting insulin production. The average participant showed a 26.9 percent decrease in fasting blood glucose levels, and an average of 16 percent decrease in hemoglobin A1C. Prior to the trial, nine of the 10 participants took oral medication and two of the patients were insulin dependent. Four of the nine participants were able to lessen their oral medication, and of the two taking insulin, one reduced the amount taken, while the other was able to completely stop taking

insulin.

The active ingredients in HPB-84 address the causes of diabetes to improve the quality of life. The ingredients, generally recognized as safe by the FDA, include bitter gourd, naja jihwa, jambul, fenugreek, bengal quince, gurmar and cinnamon. Recent clinical studies show no adverse drug interaction with HPB-84, but it is recommended that customers consult with physicians to determine the proper initial dosage.

Researchers found a number of individual success stories in the trial. One 66-year-old Caucasian male had been a Type II diabetic for thirteen years. At the beginning of the study, he was taking 14 medications and 130-140 units of insulin per day. By the end of the study, he was taking only six medications, no longer required insulin injections, and his fasting blood glucose level fell from a range of 124-155 to 99-134. A second participant reduced his average fasting blood glucose level to 110 from 270, lost 18 pounds, and is now taking half the dosage of his prescription medications.

Most Type II diabetes patients will start seeing positive results from taking HPB-84 within a short period of time, sometimes within a week, but results vary depending on the severity of symptoms, prescription medication and weight.